Biotech Values

[iwfal]

A fourth trial arm testing Telaprevir + peg-interferon without ribavirin produced poor results and will not be discussed further in this post

This smells likely a moderately good indication that modern antivirals still require immune modulating therapy to make the response durable. Shorter course perhaps. And not conclusive by any means, but ... .

Do you happen to know what the end-of-telaprevir-dosing response was in each of the arms?